John T. Treace Holds 10.9M Shares in Treace Medical Concepts

TL;DR

**Insider John T. Treace still owns over 10 million shares of Treace Medical Concepts.**

AI Summary

John T. Treace, a key figure at Treace Medical Concepts, Inc., filed an amended SC 13G/A on February 9, 2024, revealing a significant beneficial ownership of 10,903,466 shares of the company's common stock as of December 31, 2023. This includes 7,418,400 shares with sole voting and dispositive power, and 3,485,066 shares with shared voting and dispositive power. This filing is important for investors because it shows that a major insider maintains a substantial stake in the company, aligning his interests with those of shareholders.

Why It Matters

This filing confirms that a significant insider, John T. Treace, maintains a large ownership stake, which can signal confidence in the company's future to investors.

Risk Assessment

Risk Level: low — This filing indicates a stable, significant insider ownership, which generally reduces perceived risk for investors.

Analyst Insight

A smart investor would view this significant insider ownership as a positive signal, suggesting alignment between management and shareholder interests, and might consider it a factor in their investment decision for Treace Medical Concepts, Inc.

Key Numbers

• 10,903,466 — Total Shares Beneficially Owned (Represents John T. Treace's aggregate ownership in Treace Medical Concepts, Inc. as of December 31, 2023.)
• 7,418,400 — Shares with Sole Voting Power (Indicates the number of shares John T. Treace can independently vote and dispose of.)
• 3,485,066 — Shares with Shared Voting Power (Indicates the number of shares John T. Treace shares voting and dispositive control over.)

Key Players & Entities

• John T. Treace (person) — Reporting Person, beneficial owner of shares in Treace Medical Concepts, Inc.
• Treace Medical Concepts, Inc. (company) — The issuer of the securities being reported on.
• 10,903,466 (dollar_amount) — Aggregate amount of shares beneficially owned by John T. Treace.
• 7,418,400 (dollar_amount) — Shares with sole voting and dispositive power held by John T. Treace.
• 3,485,066 (dollar_amount) — Shares with shared voting and dispositive power held by John T. Treace.
• December 31, 2023 (date) — Date of event which requires filing of this statement.

Forward-Looking Statements

• John T. Treace will maintain a significant ownership stake in Treace Medical Concepts, Inc. (John T. Treace) — high confidence, target: Next 12 months

FAQ

Key Financial Figures

• $0.001 — Inc. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securiti

Filing Documents

• jttreacesched13gafeb2024.htm (SC 13G/A) — 65KB
• 0000950170-24-013360.txt ( ) — 67KB

(a) Name of Issuer

ITEM 1. (a) Name of Issuer: Treace Medical Concepts, Inc. (the “Issuer”). (b) Address of Issuer’s Principal Executive Offices: 100 Palmetto Park Place, Ponte Vedra, Florida 32081

(a) Name of Person Filing

ITEM 2. (a) Name of Person Filing: This statement is filed on behalf of John T. Treace (the “Reporting Person”). (b) Address or Principal Business Office: The business address of the Reporting Person is c/o Treace Medical Concepts, Inc., 100 Palmetto Park Place, Ponte Vedra, Florida 32081. (c) Citizenship of each Reporting Person is: The Reporting Person is a citizen of the United States. (d) Title of Class of Securities: Common stock, $0.001 par value (“Common Stock”). (e) CUSIP Number: 89455T109 ITEM 3. Not applicable. CUSIP No. 89455T109 Schedule 13G Page 3 of 5

Ownership

ITEM 4. Ownership. (a-c) The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2023, based upon 61,675,861 shares of Common Stock outstanding as of November 3, 2023, as disclosed in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 9, 2023. Reporting Person Amount beneficially owned Percent of class: Sole power to vote or to direct the vote: Shared power to vote or to direct the vote: Sole power to dispose or to direct the disposition of: Shared power to dispose or to direct the disposition of: John T. Treace 10,903,466 17.7% 7,418,400 3,485,066 7,418,400 3,485,066 John T. Treace may be deemed the beneficial owner of 10,903,466 shares of Common Stock, which include (i) 5,513,974 shares of Common Stock held of record by the Reporting Person, (ii) 1,839,063 shares of Common Stock held of record by a family trust, of which the Reporting Person is trustee, (iii) 1,605,000 shares of Common Stock held of record by Reporting Person’s spouse, (iv) 1,471,250 shares of Common Stock held of record by a family trust, of which the Reporting Person’s spouse is co-trustee, (v) 408,816 shares of Common Stock held of record by a family trust, of which the Reporting Person is co-trustee and (vi) 65,363 shares of Common Stock underlying stock options exercisable within 60 days of December 31, 2023.

Ownership of Five Percent or Less of a Class

ITEM 5. Ownership of Five Percent or Less of a Class. Not applicable.

Ownership of More than Five Percent on Behalf of Another Person

ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.

Identification and Classification of Members of the Group

ITEM 8. Identification and Classification of Members of the Group. Not applicable.

Notice of Dissolution of Group

ITEM 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 89455T109 Schedule 13G Page 4 of 5

Certification

ITEM 10. Certification. Not applicable. CUSIP No. 89455T109 Schedule 13G Page 5 of 5 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date : February 9, 2024 John T. Treace /s/ John T. Treace